TL011
NHL-TL011-102
Phase 1 mab completed
Quick answer
TL011 for DLBCL is a Phase 1 program (mab) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- DLBCL
- Phase
- Phase 1
- Modality
- mab
- Status
- completed